Bayer to Invest 2.2 Billion U.S. Dollars in a New Manufacturing Site in the United States

What happened: Bayer announced plans to invest 2.2 billion U.S. dollars in a new pharmaceutical manufacturing site in New Albany, Ohio, combining drug substance and drug product manufacturing. Key numbers: 2.2 billion dollars investment; around 600 high-value jobs; roughly 1,500 construction jobs; more than seven billion dollars in U.S. Why it matters: Bayer calls the project a central element of its long-term growth strategy and cites the U.S. as its fastest-growing pharmaceuticals market, with the site serving patients in the U.S. and globally.

Bayer announced plans to invest 2.2 billion U.S. dollars in a new pharmaceutical manufacturing site in New Albany, Ohio, combining drug substance and drug product manufacturing.

Bayer calls the project a central element of its long-term growth strategy and cites the U.S. as its fastest-growing pharmaceuticals market, with the site serving patients in the U.S. and globally.